APA (7th ed.) Citation

Harter, C., Schulze, B., Goldschmidt, H., Benner, A., Geiss, H. K., Hoppe-Tichy, T., . . . Egerer, G. (2006). Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: A prospective randomized trial. Bone marrow transplantation, 37(4), . https://doi.org/10.1038/sj.bmt.1705256

Chicago Style (17th ed.) Citation

Harter, Christoph, Birte Schulze, Hartmut Goldschmidt, Axel Benner, Heinrich K. Geiss, Torsten Hoppe-Tichy, Anthony Dick Ho, and Gerlinde Egerer. "Piperacillin/tazobactam Vs Ceftazidime in the Treatment of Neutropenic Fever in Patients with Acute Leukemia or Following Autologous Peripheral Blood Stem Cell Transplantation: A Prospective Randomized Trial." Bone Marrow Transplantation 37, no. 4 (2006). https://doi.org/10.1038/sj.bmt.1705256.

MLA (9th ed.) Citation

Harter, Christoph, et al. "Piperacillin/tazobactam Vs Ceftazidime in the Treatment of Neutropenic Fever in Patients with Acute Leukemia or Following Autologous Peripheral Blood Stem Cell Transplantation: A Prospective Randomized Trial." Bone Marrow Transplantation, vol. 37, no. 4, 2006, https://doi.org/10.1038/sj.bmt.1705256.